Company: BNBX
Filing Date: 2025-10-30
Form Type: S-1
Source: 0001104659-25-103871
Chunk: 178

Company: BNB PLUS CORP.
Filing Date: 2025-10-30
Form: S-1
Chunk 178
---
 | -993,100 | ​ | ​        | -4,809,000 | ​ | ​      | -9,430,000 |
| Fair Value at September 30, 2024          | ​ | $        |     27,000 | ​ | $        |     15,000 | ​ | $         |   16,000 | ​ | $        |    262,000 | ​ | $      |    320,000 |

F-27

NOTE M — SUBSEQUENT EVENTS Registered Direct Offering and Concurrent Private Placement On October 31, 2024, the Company closed a registered direct offering (the “October Registered Direct Offering”) in which, pursuant to the Securities Purchase Agreement dated October 31, 2024 (the “October Purchase Agreement”), by and between the Company and certain institutional investors (the “October Purchasers”), the Company issued and sold 19,247,498shares of the Company’s Common Stock, and pre-funded warrants (“October Pre-Funded Warrants”) to purchase up to 1,065,002shares of Common Stock, and (ii) in a concurrent private placement (the “October Private Placement”, and together with the October Registered Direct Offering the “October Offering”), unregistered Series C Common Stock Purchase Warrants (“October Series C Warrants”) to purchase up to 20,312,500shares of Common Stock and unregistered Series D Common Stock Purchase Warrants (“October Series D Warrants”, and together with the October Series C Warrants, the “October Series Warrants”, and, together with the October Pre-Funded Warrants and the October Series C Warrants, the “October Warrants”) to purchase up to 20,312,500shares of Common Stock. The purchase price for each share of Common Stock and accompanying October Series C Warrant and October Series D Warrant was $ 0.32and the purchase price for each October Pre-Funded Warrant and accompanying October Series C Warrant and October Series D Warrant was $ 0.3199. Craig-Hallum acted as placement agent in connection with the October Offering. The Company received gross proceeds from the October Offering, before deducting placement agent fees and other estimated offering expenses payable by the Company, of approximately $ 6.5million. The exercisability of the October Series Warrants and the October Placement Agent Warrants will be available only upon receipt of such stockholder approval (“Warrant Stockholder Approval”) as may be required by the applicable